Pembrolizumab in the treatment of non-small cell lung cancer-experiences from clinical practice.

Front Med (Lausanne) · 2025 · PMC12434102 · PMID 40959419

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a notable trendno p-value reported

Over the past decades, a notable trend for declining average ages at diagnosis has been observed.

also in 2,380 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.